Prevalence of Sleep Apnea in Patients Undergoing Surgery for Colorectal Cancer

September 25, 2024 updated by: Karl A Franklin

212 patients with colorectal cancer will be investigated before surgery and 100 of them after surgery. 597 individuals from a previous population based study will serve as controls to the prevalence of sleep apnea in the general population.

Investigations will include polysomonographic sleep apnea recordings during one night, lung function measurements, blood gas samples and questionnaires.

Controls: Men and women from two population-based cohort studies

Study Overview

Detailed Description

Inclusion: 212 patients with colorectal cancer will be investigated before surgery and 100 of them will also be investigated in the same manner after surgery. Due to drop-outs we calculate a need of inviting at least 250 patients.

Controls: 597 individuals from a previous population based study will serve as controls to the prevalence of sleep apnea in the general population.

Exclusion: Dementia, CPAP treated sleep apnea investigations: Patients are investigated with lung function, blood-gas samples, questionnaires, overnight polysomnographic sleep apnea recordings including oro-nasal airflow, thoraco-abdominal respiration belts, chin-EMG, EOG, EEG, ECG (V5) and body position.

Controls: Men and women from two population-based cohort studies the "Sleep and health in women" and the "Men in Uppsala: A Study of Sleep, Apnea and Cardiometabolic Health" and older men and women from a local senior organization.

Outcomes: Prevalence of sleep apnea and hypoxia, sleep quality, and lung function, blood gas, STOP-BANG, Epworth sleepiness scale, Mallampati score, symptoms of sleep apnea, surgical complications, mortality, cancer severity.

Study Type

Observational

Enrollment (Actual)

212

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Umea
      • Umeå, Umea, Sweden, 901 85
        • Dept of Surgery, Inst of Surgical and Perioperative sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Patients scheduled for surgery of colorectal cancer Healthy volunteers from population based studies will be included as controls

Description

Inclusion Criteria:

  • Patients scheduled for surgery of colorectal cancer

Exclusion Criteria:

  • Dementia, CPAP treatment for obstructive sleep apnea

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Before surgery
patients scheduled for surgery of colorectal cancer
Includes open and minimally invasive surgery for colon- and rectal cancer
Control subjects
Controls from the population without colorectal cancer
This is a control group from the population. They are not scheduled for surgery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of sleep apnea
Time Frame: 1 week
Apnea-hypopnea index
1 week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sleep quality
Time Frame: 1 week
total sleep time, sleep efficiency, time in different sleep stages
1 week
hypoxia, hypercapnia
Time Frame: 1 week
blood-gas measurements
1 week
lung function
Time Frame: 1 week
FVC, FEV1
1 week
subjective sleepiness
Time Frame: 1 week
Eworth sleepiness scale
1 week
Mortality
Time Frame: Until death
From the swedish death register
Until death
Side effects of surgery
Time Frame: 30 days
From local register
30 days
Severity of cancer
Time Frame: 30 days
Morphologic analysis of cancer type
30 days
nocturnal hypoxia
Time Frame: 1 week
Pulsoximetry during polysomnography
1 week
Mallampati score
Time Frame: 1 day
Inspection of mouth
1 day
STOP-Bang
Time Frame: 1 week
Risk factor stratification
1 week
Symptoms of sleep apnea
Time Frame: 1 month
snoring, daytime sleepiness, witnessed sleep apneas
1 month
Sex differences
Time Frame: 1 month
Effect of sex on outcome
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Kar A Franklin, Ass prof, Dept of Surgical and perioperative sciences, Umeå University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 7, 2015

Primary Completion (Actual)

April 28, 2021

Study Completion (Actual)

February 28, 2022

Study Registration Dates

First Submitted

December 11, 2014

First Submitted That Met QC Criteria

December 22, 2014

First Posted (Estimated)

December 23, 2014

Study Record Updates

Last Update Posted (Actual)

September 27, 2024

Last Update Submitted That Met QC Criteria

September 25, 2024

Last Verified

September 1, 2024

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe